For the Quarter Ending March 2026
Rabeprazole Prices in North America
- In the United States, the Rabeprazole Price Index rose quarter-over-quarter in Q1 2026, driven by escalating API manufacturing costs.
- The Rabeprazole Production Cost Trend increased in March 2026 as producer prices rose 4.0 percent year-over-year.
- Consumer prices increased 3.3 percent year-over-year in March 2026, while retail sales grew 4.0 percent, supporting pharmacy purchases.
- The Rabeprazole Demand Outlook strengthened in March 2026, supported by a 4.3 percent unemployment rate and 91.8 percent consumer confidence.
- Industrial production grew 0.7 percent year-over-year in March 2026, while the manufacturing index expanded, ensuring stable pharmaceutical production.
- Methanol feedstock costs surged in Q1 2026, while global crude oil prices spiked during March 2026 geopolitical disruptions.
- United States methanol supply and global trade flows tightened significantly in Q1 2026 due to domestic production outages.
- The Rabeprazole Price Forecast indicated an upward trajectory in Q1 2026, reflecting inflated upstream petrochemical input costs.
Why did the price of Rabeprazole change in March 2026 in North America?
- Methanol feedstock costs surged in Q1 2026 due to domestic production outages and tightening supply.
- Active pharmaceutical ingredient manufacturing costs escalated in Q1 2026 amid a 4.0 percent producer price increase.
- Strong retail sales and stable unemployment in March 2026 sustained robust consumer demand at pharmacies.
Rabeprazole Prices in Europe
- In Germany, the Rabeprazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging pharmaceutical preparation costs.
- Higher inflation at 2.7% in March 2026 and a stable 4.2% unemployment rate in February 2026 supported demand.
- The Rabeprazole Production Cost Trend experienced mixed pressures as producer prices declined 0.2% in March 2026.
- Industrial production remained stagnant at 0.0% in February 2026, while retail sales grew 0.7%, boosting the Rabeprazole Demand Outlook.
- Consumer confidence hit -24.7 in March 2026, yet the Manufacturing Index expanded, reflecting robust sector activity in Q1 2026.
- Spot prices for toluene, a key feedstock, spiked globally in March 2026, elevating the Rabeprazole Price Index.
- European chemical import availability tightened significantly in March 2026, while downstream buyers built inventory in February 2026.
- National natural gas storage levels plummeted to historic lows in March 2026, impacting the Rabeprazole Price Forecast.
Why did the price of Rabeprazole change in March 2026 in Europe?
- Toluene feedstock spot prices spiked globally in March 2026, directly increasing regional pharmaceutical manufacturing expenses.
- European chemical import availability and regional inventories tightened significantly amid logistical disruptions in March 2026.
- National natural gas storage plummeted to historic lows in March 2026, elevating energy input costs.
Rabeprazole Prices in APAC
- In China, the Rabeprazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging toluene solvent costs.
- Consumer inflation reached 1.0% year-over-year and retail sales grew 1.7% in March 2026, supporting downstream pharmaceutical consumption.
- Factory-gate prices increased 0.5% year-over-year in March 2026, reflecting the elevated Rabeprazole Production Cost Trend from aromatics.
- Industrial production grew 5.7% year-over-year, and the Manufacturing Index expanded in March 2026, boosting chemical sector activity.
- The 5.4% unemployment rate in March 2026 and the 89.5 consumer confidence index in Q1 2026 constrained discretionary spending.
- The Rabeprazole Demand Outlook strengthened in March 2026 as pharmaceutical demand for proton pump inhibitors increased significantly.
- Over-the-counter market access expanded and digestive drug demand strengthened across the regional healthcare sector in March 2026.
- The Rabeprazole Price Forecast stabilized in March 2026 as generic API supply expanded following increased backward integration.
Why did the price of Rabeprazole change in March 2026 in APAC?
- Toluene solvent costs for API synthesis surged amid energy market volatility in March 2026.
- Upstream aromatics feedstock costs fluctuated due to crude oil market volatility throughout Q1 2026.
- Market availability of generic formulations broadened significantly due to patent expirations in March 2026.
For the Quarter Ending December 2025
Rabeprazole Prices in North America
- In the United States, the Rabeprazole Price Index rose in Q4 2025, influenced by rising costs and robust demand.
- Rabeprazole production costs increased, driven by a 3.0% year-over-year Producer Price Index rise in November 2025.
- The Consumer Price Index increased 2.7% year-over-year in December 2025, adding to manufacturers' operational expenses.
- Rabeprazole demand outlook was positive, supported by a 3.3% retail sales increase in November 2025.
- A 4.4% US unemployment rate in December 2025 indicated strong consumer spending and healthcare access.
- Industrial production expanded 2.0% year-over-year in December 2025, supporting a stable supply chain for Rabeprazole.
- Natural gas prices surged temporarily in early December 2025, impacting production costs before receding.
- Global oil inventories expanded to multi-year highs in October 2025, with stock builds continuing into November.
- The pharmaceutical market experienced an upturn in Q4 2025, signaling renewed confidence for Rabeprazole products.
Why did the price of Rabeprazole change in December 2025 in North America?
- Rabeprazole production costs increased due to a 2.7% year-over-year CPI rise in December 2025.
- Strong consumer spending, evidenced by a 3.3% year-over-year retail sales increase in November 2025, supported demand.
- Temporary natural gas price surges in early December 2025 impacted Rabeprazole manufacturing expenses.
Rabeprazole Prices in APAC
- In China, the Rabeprazole Price Index fell in Q4 2025, influenced by decreasing producer prices and weak consumer demand.
- Rabeprazole production costs faced downward pressure in December 2025, as the Producer Price Index declined 1.9% year-on-year.
- The Rabeprazole demand outlook was mixed, with retail sales growing only 0.9% year-on-year in December 2025.
- Manufacturing industry demand for Rabeprazole intermediates improved in December 2025, moving into the expansionary range.
- China's industrial production grew 5.2% year-on-year in December 2025, supporting stable supply chains for Rabeprazole.
- Inventories of main raw materials declined in October and November 2025, with the decline narrowing in December.
- The chemical industry prosperity index tumbled into contraction by November 2025, reflecting broader sector challenges.
- New export sales for chemicals, including Rabeprazole, experienced a modest decline in December 2025.
Why did the price of Rabeprazole change in December 2025 in APAC?
- Producer Price Index declined 1.9% year-on-year in December 2025, lowering Rabeprazole production costs.
- Weak consumer demand, with 0.8% CPI and 0.9% retail sales growth in December 2025, pressured Rabeprazole.
- Record chemical sector overcapacity in China during 2025 contributed to downward pressure on Rabeprazole.
Rabeprazole Prices in Europe
- In Germany, the Rabeprazole Price Index remained stable quarter-over-quarter in Q4 2025, influenced by a 2.5% decline in producer prices in December.
- Rabeprazole production costs decreased in December 2025 due to a 2.5% decline in producer prices, despite elevated energy costs.
- Demand for Rabeprazole increased in Germany's pharmaceutical market in 2025, driven by an aging population and chronic diseases.
- Operational costs faced pressure from 1.8% consumer price inflation in December 2025.
- Industrial production grew 0.8% in October 2025, while retail sales increased 1.1% in November.
- The Manufacturing Index contracted in Germany in December 2025, reflecting a broader economic slowdown.
- Consumer confidence remained negative at -17.5 in December 2025, with unemployment at 6.2%.
- European acetone markets experienced oversupply and weakened prices in 2025, impacting Rabeprazole production costs.
- Global methanol production contracted in Q4 2025 due to natural gas feedstock limitations, affecting supply.
Why did the price of Rabeprazole change in December 2025 in Europe?
- Producer Price Index declined 2.5% in December 2025, reducing raw material and intermediate chemical costs.
- Elevated natural gas prices throughout 2025 pressured German chemical and pharmaceutical businesses.
- Germany's pharmaceutical market demand increased in 2025, driven by an aging population and chronic diseases.
For the Quarter Ending September 2025
Rabeprazole Prices in North America
- In United States, the Rabeprazole Price Index remained stable quarter-over-quarter in Q3 2025, despite rising input costs.
- Rabeprazole production costs increased in Q3 2025, driven by a 2.6% year-over-year PPI rise in August 2025.
- Demand for Rabeprazole was supported by a 5.42% year-over-year increase in retail sales in September 2025.
- The Rabeprazole Price Forecast faces pressure from an overall uptick in natural gas prices year-over-year in Q3 2025.
- Overall chemical manufacturing activity contracted in Q3 2025, impacting Rabeprazole supply.
- US national health expenditures grew in 2025, strengthening the broader healthcare sector for Rabeprazole demand.
- A 4.3% unemployment rate in September 2025 supported Rabeprazole demand by enhancing patient access and affordability.
- Inflationary pressures, with CPI up 3.0% year-over-year in September 2025, impacted overall production expenses.
- Raw material inventory levels for chemical manufacturers contracted or remained stable in Q3 2025.
Why did the price of Rabeprazole change in September 2025 in North America?
- Rising production costs, influenced by a 2.6% year-over-year PPI increase in August 2025, pressured prices.
- Strong consumer spending, with retail sales up 5.42% year-over-year in September 2025, supported demand.
- Contracting chemical manufacturing activity in Q3 2025, alongside stable inventories, influenced supply.
Rabeprazole Prices in APAC
- In China, the Rabeprazole Price Index declined quarter-over-quarter in Q3 2025, influenced by deflationary pressures.
- Rabeprazole production costs fell in Q3 2025, as producer prices declined 2.3% year-on-year in September 2025.
- Demand for Rabeprazole was supported by robust pharmaceutical market expansion and 6.5% industrial production growth in September 2025.
- The Rabeprazole Price Index faced downward pressure in Q3 2025, reflecting 0.3% consumer price deflation in September 2025.
- China's pharmaceutical market experienced robust expansion in Q3 2025, driven by an aging population and chronic diseases.
- Global oil inventories rose in Q3 2025, contributing to downward pressure on crude oil prices, impacting energy costs.
- The Manufacturing Index indicated a contracting sector in September 2025, suggesting a broader economic slowdown.
- Government initiatives bolstered pharmaceutical innovation and high-end biopharma production in China during Q3 2025.
Why did the price of Rabeprazole change in September 2025 in APAC?
- Deflationary pressures, with CPI falling 0.3% year-on-year in September 2025, exerted downward pressure.
- Producer prices declined 2.3% year-on-year in September 2025, reducing raw material and manufacturing costs.
- A contracting Manufacturing Index in September 2025 signaled weak industrial demand, impacting overall pricing.
Rabeprazole Prices in Europe
- In Germany, the Rabeprazole Price Index remained stable in Q3 2025, reflecting mixed macroeconomic pressures.
- Rabeprazole production costs eased in Q3 2025 due to declining benzene, methanol, and naphtha feedstock prices.
- Demand for pharmaceutical products, including Rabeprazole, strengthened in Q3 2025, driven by an aging population.
- Producer prices decreased by 1.7% year-over-year in September 2025, lowering Rabeprazole manufacturing input costs.
- Consumer confidence declined significantly to -23.6 in September 2025, impacting OTC Rabeprazole demand.
- High energy costs and 2.4% CPI in September 2025 pressured Rabeprazole operating expenses.
- Industrial production contracted by 1.0% year-over-year in September 2025, affecting overall healthcare budgets.
- Retail sales grew modestly by 0.8% year-over-year in September 2025, while unemployment was 3.9%.
- Ample chemical inventories and increased pharmaceutical imports in Q3 2025 intensified market competition.
Why did the price of Rabeprazole change in September 2025 in Europe?
- Producer prices decreased by 1.7% year-over-year in September 2025, reducing Rabeprazole input costs.
- High energy costs and 2.4% CPI in September 2025 pressured Rabeprazole operating expenses.
- Increased pharmaceutical imports and ample inventories in Q3 2025 intensified market competition.
